Valo Health is a pioneering technology company that is transforming the drug discovery and development process. They leverage human-centric data and AI-powered computation to revolutionize the way we approach medicine.

Their proprietary drug development platform, Opal, is at the heart of their operations. Opal uses AI to identify and advance a diverse range of programs across various disease areas, including cardiovascular-metabolic-renal diseases, oncology, and neurodegenerative diseases. This platform allows Valo Health to streamline the drug discovery process, making it more efficient and effective.

Valo Health’s unique approach integrates data across the entire drug development lifecycle. By harnessing the power of machine learning and patient data, they are able to accelerate the discovery and development of life-changing treatments. This innovative method has the potential to significantly reduce the time and cost associated with traditional drug discovery methods.

Based in Boston, Valo Health is composed of a team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers. Their cross-disciplinary collaboration and innovative spirit are key to their success in changing the landscape of drug discovery and development.